VitiligoWeb.com
I have written about Clinuvel and Scenesse before, but now they have reported the start of a final phase III test of the drug in the US. This drug is targetted to people with EPP, a light intolerance disorder, but also may have applications for Vitiligo.
The trial will last six months and we will be watching for the results. There are very few drugs in trial for Vitiligo right now.
To read the news, click below:
http://www.lifescientist.com.au/article/425416/clinuvel_starts_final_trial_scenesse_epp/
No comments:
Post a Comment